-Effect of Novoalign alignment score threshold Effect of Novoalign t parameter on alignment 3me (A) and alignment efficiency (B). 
-Observed VAFs for plaAnum calls in sample 1 (100% NA12878) and sample 12 (100% NA11840) (A) VAF versus depth of coverage plot for 9968 NA12878 pla3num SNVs. (B) Histogram of VAF distribu3on for 9968 NA12878 pla3num SNVs in the NA11840 sample. Bam files from the NovocraQ pipeline have been used. Figure S4 -False posiAves in the NA12878 diluAon series (A) FPR/Mb in the NA12878 dilu3on series using Strelka in combina3on with each alignment pipeline. All calls not in the list of 9968 pla3num SNVs were here on considered as false posi3ves. The number of false posi3ve has an unexpected associa3on with the percentage of NA12878, sugges3ng that most of them are actually real muta3ons not in the pla3num calls, possibly acquired by the cell line during in vitro culturing. (B, C) Intersec3on between false posi3ves in the 100% and 80% NA12878 samples (top) and 0.5% and 0.2% NA12878 samples (bo^om) using Strelka in combina3on with BWA/GATK pipeline (B) or NovocraQ pipeline (C). The fact that most of false posi3ves in the 100% and 80% NA12878 sample overlap and none of them overlap in the diluted samples jus3fied our choice to es3mate the FPR/Mb in the 0.2% NA12878 sample.
Figure S5 -Reason of rejecAon in Mutect2 for false negaAve calls
For the subset of false nega3ve calls in Mutect2 aQer BWA/GATK, we summarized how many calls failed each filter in the 100% NA12878 sample (A) and 10% NA12878 sample (B). The same informa3on is reported in C and D for Mutect2 aQer NovocraQ alignment. Figure S6 -Adjustment of filtering parameters in BWA/GATK/Mutect2 SNV calls Sensi3vity (top) and FPR/Mb (bo^om) varia3ons in the 100% NA12878 sample aQer changing the percentage of tolerated alterna3ve allele in the matched normal (A). In addi3on to each percentage threshold we applied a threshold to the tumour/normal VAF ra3o from 0 to 10 (x-axis), with lower values associated with higher FPR/Mb. (B) As in (A) but in the 10% NA12878 sample. (C) Sensi3vity and FPR/Mb varia3ons in the 100% NA12878 sample as a func3on of the tumour LOD (log odds) score threshold applied. (D) As in C but in the 10% NA12878 sample. Figure S10 -Performance of the intersect-then-combine approach, heterozygous mutaAons only (A) Sensi3vity in iden3fying SNVs aQer applying the ITC strategy compared with performance using each single alignment pipeline in combina3on with each muta3on caller. Only SNVs heterozygous in NA12878 sample are included. (B) Sensi3vity in iden3fying 'soma3c' Indels aQer applying the ITC strategy compared with performance using each single alignment pipeline in combina3on with each muta3on caller. Only Indels heterozygous in NA12878 sample are included. 
